1260663-93-1,MFCD18250873
Catalog No.:AA000QWW

1260663-93-1 | 6-Chloro-2,7-naphthyridin-1(2H)-one

Pack Size
Purity
Availability
Price(USD)
Quantity
  
100mg
95%
in stock  
$15.00   $11.00
- +
250mg
95%
in stock  
$28.00   $20.00
- +
1g
95%
in stock  
$82.00   $57.00
- +
5g
95%
in stock  
$406.00   $284.00
- +
10g
95%
in stock  
$811.00   $568.00
- +
  • Technical Information
  • Properties
  • Downstream Synthesis Route
  • Literature
  • Request for Quotation
  • Download SDS
Technical Information
Catalog Number:
AA000QWW
Chemical Name:
6-Chloro-2,7-naphthyridin-1(2H)-one
CAS Number:
1260663-93-1
Molecular Formula:
C8H5ClN2O
Molecular Weight:
180.5911
MDL Number:
MFCD18250873
SMILES:
Clc1ncc2c(c1)cc[nH]c2=O
Properties
Computed Properties
 
Complexity:
229  
Covalently-Bonded Unit Count:
1  
Heavy Atom Count:
12  
Hydrogen Bond Acceptor Count:
2  
Hydrogen Bond Donor Count:
1  
XLogP3:
1.2  

Downstream Synthesis Route

[1]CurrentPatentAssignee:CUREGENIXINC-WO2013/185353,2013,A1

[2]CurrentPatentAssignee:CUREGENIXINC-WO2014/159733,2014,A1

[3]CurrentPatentAssignee:CUREGENIXINC-WO2014/165232,2014,A1

[4]CurrentPatentAssignee:CUREGENIXINC-US2015/119387,2015,A1

[5]CurrentPatentAssignee:CUREGENIXINC-JP2017/95498,2017,A

[6]CurrentPatentAssignee:CUREGENIXINC;GUANGZHOUYUANSHENGPHARMACEUTICALSCIENCESTECHNO-CN104530042,2017,B

[7]CurrentPatentAssignee:SYROSPHARMACEUTICALSINC-WO2019/14513,2019,A1

[8]CurrentPatentAssignee:CUREGENIXINC-WO2016/191525,2016,A1

[1]CurrentPatentAssignee:CUREGENIXINC-WO2013/185353,2013,A1

[2]CurrentPatentAssignee:CUREGENIXINC-WO2014/159733,2014,A1

[3]CurrentPatentAssignee:CUREGENIXINC-WO2014/165232,2014,A1

[4]CurrentPatentAssignee:CUREGENIXINC-US2015/119387,2015,A1

[5]CurrentPatentAssignee:CUREGENIXINC-JP2017/95498,2017,A

[6]CurrentPatentAssignee:CUREGENIXINC;GUANGZHOUYUANSHENGPHARMACEUTICALSCIENCESTECHNO-CN104530042,2017,B

[7]CurrentPatentAssignee:SYROSPHARMACEUTICALSINC-WO2019/14513,2019,A1

[8]CurrentPatentAssignee:CUREGENIXINC-WO2016/191525,2016,A1

950746-21-1   
6-chloro-2,7-naphthyridin-1-(2H)-one 

[1]Patent:WO2013/185353,2013,A1

[2]Patent:WO2014/159733,2014,A1

[3]Patent:WO2014/165232,2014,A1

[4]Patent:US2015/119387,2015,A1

[5]Patent:JP2017/95498,2017,A

[6]Patent:CN104530042,2017,B

[7]Patent:WO2019/14513,2019,A1

[8]Patent:WO2016/191525,2016,A1

[1]CurrentPatentAssignee:CUREGENIXINC-WO2013/185353,2013,A1Locationinpatent:Page/Pagecolumn22

[2]CurrentPatentAssignee:CUREGENIXINC-WO2014/165232,2014,A1Locationinpatent:Paragraph0182;0183

[3]CurrentPatentAssignee:CUREGENIXINC-US2015/119387,2015,A1Locationinpatent:Paragraph0183;0184

[4]CurrentPatentAssignee:CUREGENIXINC-JP2017/95498,2017,ALocationinpatent:Paragraph0091;0092

[5]CurrentPatentAssignee:CUREGENIXINC;GUANGZHOUYUANSHENGPHARMACEUTICALSCIENCESTECHNO-CN104530042,2017,BLocationinpatent:Paragraph0171;0189;0190;0191

[6]CurrentPatentAssignee:CUREGENIXINC-WO2014/159733,2014,A1Locationinpatent:Paragraph0168-0169

[7]CurrentPatentAssignee:SYROSPHARMACEUTICALSINC-WO2019/14513,2019,A1Locationinpatent:Paragraph0178

[8]CurrentPatentAssignee:CUREGENIXINC-WO2016/191525,2016,A1Locationinpatent:Paragraph0237-0238

[1]CurrentPatentAssignee:CUREGENIXINC-WO2013/185353,2013,A1Locationinpatent:Page/Pagecolumn22;23

[2]CurrentPatentAssignee:CUREGENIXINC-WO2014/165232,2014,A1Locationinpatent:Paragraph0184;0185

[3]CurrentPatentAssignee:CUREGENIXINC-US2015/119387,2015,A1Locationinpatent:Paragraph0185;0186

[4]CurrentPatentAssignee:CUREGENIXINC-JP2017/95498,2017,ALocationinpatent:Paragraph0094;0095

[5]CurrentPatentAssignee:CUREGENIXINC;GUANGZHOUYUANSHENGPHARMACEUTICALSCIENCESTECHNO-CN104530042,2017,BLocationinpatent:Paragraph0171;0192;0193;0194

[6]CurrentPatentAssignee:CUREGENIXINC-WO2014/159733,2014,A1Locationinpatent:Paragraph0170-0171

[7]CurrentPatentAssignee:CUREGENIXINC-WO2016/191525,2016,A1Locationinpatent:Paragraph0239-0240

Literature
Quotation Request
Company Name:
*
Contact Person:
*
Email:
*
Quantity Required:
*
Country:
Additional Info:
SDS
Tags:1260663-93-1 Molecular Formula|1260663-93-1 MDL|1260663-93-1 SMILES|1260663-93-1 6-Chloro-2,7-naphthyridin-1(2H)-one
Catalog No.: AA000QWW
1260663-93-1,MFCD18250873
1260663-93-1 | 6-Chloro-2,7-naphthyridin-1(2H)-one
Pack Size: 100mg
Purity: 95%
in stock
$15.00 $11.00
Pack Size: 250mg
Purity: 95%
in stock
$28.00 $20.00
Pack Size: 1g
Purity: 95%
in stock
$82.00 $57.00
Pack Size: 5g
Purity: 95%
in stock
$406.00 $284.00
Pack Size: 10g
Purity: 95%
in stock
$811.00 $568.00
Quantity
- +
Add to Card
Order Now
bulk Quotation Request
Technical Information
Catalog Number: AA000QWW
Chemical Name: 6-Chloro-2,7-naphthyridin-1(2H)-one
CAS Number: 1260663-93-1
Molecular Formula: C8H5ClN2O
Molecular Weight: 180.5911
MDL Number: MFCD18250873
SMILES: Clc1ncc2c(c1)cc[nH]c2=O
Properties
Complexity: 229  
Covalently-Bonded Unit Count: 1  
Heavy Atom Count: 12  
Hydrogen Bond Acceptor Count: 2  
Hydrogen Bond Donor Count: 1  
XLogP3: 1.2  
Downstream Synthesis Route
875-35-4    1260663-93-1 

[1]CurrentPatentAssignee:CUREGENIXINC-WO2013/185353,2013,A1

[2]CurrentPatentAssignee:CUREGENIXINC-WO2014/159733,2014,A1

[3]CurrentPatentAssignee:CUREGENIXINC-WO2014/165232,2014,A1

[4]CurrentPatentAssignee:CUREGENIXINC-US2015/119387,2015,A1

[5]CurrentPatentAssignee:CUREGENIXINC-JP2017/95498,2017,A

[6]CurrentPatentAssignee:CUREGENIXINC;GUANGZHOUYUANSHENGPHARMACEUTICALSCIENCESTECHNO-CN104530042,2017,B

[7]CurrentPatentAssignee:SYROSPHARMACEUTICALSINC-WO2019/14513,2019,A1

[8]CurrentPatentAssignee:CUREGENIXINC-WO2016/191525,2016,A1

1175559-53-1    1260663-93-1 

[1]CurrentPatentAssignee:CUREGENIXINC-WO2013/185353,2013,A1

[2]CurrentPatentAssignee:CUREGENIXINC-WO2014/159733,2014,A1

[3]CurrentPatentAssignee:CUREGENIXINC-WO2014/165232,2014,A1

[4]CurrentPatentAssignee:CUREGENIXINC-US2015/119387,2015,A1

[5]CurrentPatentAssignee:CUREGENIXINC-JP2017/95498,2017,A

[6]CurrentPatentAssignee:CUREGENIXINC;GUANGZHOUYUANSHENGPHARMACEUTICALSCIENCESTECHNO-CN104530042,2017,B

[7]CurrentPatentAssignee:SYROSPHARMACEUTICALSINC-WO2019/14513,2019,A1

[8]CurrentPatentAssignee:CUREGENIXINC-WO2016/191525,2016,A1

950746-21-1   
6-chloro-2,7-naphthyridin-1-(2H)-one 

[1]Patent:WO2013/185353,2013,A1

[2]Patent:WO2014/159733,2014,A1

[3]Patent:WO2014/165232,2014,A1

[4]Patent:US2015/119387,2015,A1

[5]Patent:JP2017/95498,2017,A

[6]Patent:CN104530042,2017,B

[7]Patent:WO2019/14513,2019,A1

[8]Patent:WO2016/191525,2016,A1

1385818-35-8    1260663-93-1 

[1]CurrentPatentAssignee:CUREGENIXINC-WO2013/185353,2013,A1Locationinpatent:Page/Pagecolumn22

[2]CurrentPatentAssignee:CUREGENIXINC-WO2014/165232,2014,A1Locationinpatent:Paragraph0182;0183

[3]CurrentPatentAssignee:CUREGENIXINC-US2015/119387,2015,A1Locationinpatent:Paragraph0183;0184

[4]CurrentPatentAssignee:CUREGENIXINC-JP2017/95498,2017,ALocationinpatent:Paragraph0091;0092

[5]CurrentPatentAssignee:CUREGENIXINC;GUANGZHOUYUANSHENGPHARMACEUTICALSCIENCESTECHNO-CN104530042,2017,BLocationinpatent:Paragraph0171;0189;0190;0191

[6]CurrentPatentAssignee:CUREGENIXINC-WO2014/159733,2014,A1Locationinpatent:Paragraph0168-0169

[7]CurrentPatentAssignee:SYROSPHARMACEUTICALSINC-WO2019/14513,2019,A1Locationinpatent:Paragraph0178

[8]CurrentPatentAssignee:CUREGENIXINC-WO2016/191525,2016,A1Locationinpatent:Paragraph0237-0238

1260663-93-1    1335053-95-6 

[1]CurrentPatentAssignee:CUREGENIXINC-WO2013/185353,2013,A1Locationinpatent:Page/Pagecolumn22;23

[2]CurrentPatentAssignee:CUREGENIXINC-WO2014/165232,2014,A1Locationinpatent:Paragraph0184;0185

[3]CurrentPatentAssignee:CUREGENIXINC-US2015/119387,2015,A1Locationinpatent:Paragraph0185;0186

[4]CurrentPatentAssignee:CUREGENIXINC-JP2017/95498,2017,ALocationinpatent:Paragraph0094;0095

[5]CurrentPatentAssignee:CUREGENIXINC;GUANGZHOUYUANSHENGPHARMACEUTICALSCIENCESTECHNO-CN104530042,2017,BLocationinpatent:Paragraph0171;0192;0193;0194

[6]CurrentPatentAssignee:CUREGENIXINC-WO2014/159733,2014,A1Locationinpatent:Paragraph0170-0171

[7]CurrentPatentAssignee:CUREGENIXINC-WO2016/191525,2016,A1Locationinpatent:Paragraph0239-0240

Building Blocks More >
1260840-42-3
1260840-42-3
Ethyl 6-bromo-[1,2,4]triazolo[4,3-a]pyridine-3-carboxylate
AA000RD3 | MFCD11975672
1261513-55-6
1261513-55-6
4-Bromo-3-(difluoromethyl)phenol
AA000RQL | MFCD18391153
1261891-38-6
1261891-38-6
4-(4-Carboxyphenyl)-2-chlorobenzoic acid
AA000S07 | MFCD18320286
1261940-28-6
1261940-28-6
1-BOC- 2-(2-(3-trifluoromethylphenoxy)ethyl)piperidine
AA000S4B | MFCD18311884
1261977-82-5
1261977-82-5
5-(4-Cyanophenyl)-2-fluorobenzoic acid
AA000S88 | MFCD18319153
1263198-93-1
1263198-93-1
(R)-3-Methyl-1-phenylbutan-1-amine hydrochloride
AA000SHH | MFCD12910550
126533-79-7
126533-79-7
Ethyl 2-((4-methoxyphenyl)amino)thiazole-4-carboxylate
AA000STA | MFCD07369005
126822-39-7
126822-39-7
4-Cyclopropylpyrrolidin-2-one
AA000T73 | MFCD18816888
129779-30-2
129779-30-2
1-Boc-cis-3,5-dimethyl-piperazine
AA000TLJ | MFCD06795911
130110-09-7
130110-09-7
(1-Phenyl-2-pyrrolidinylethyl)methylamine
AA000TXL | MFCD03426435
Submit
© 2017 AA BLOCKS, INC. All rights reserved.